Ali Sefa Mendĭl
Impact in
-
- Drug-Induced Hepatotoxicity and Protection
-
- Liver Disease and Transplantation
Papers in
-
- Pineapple and bromelain studies 2
- Genomics, phytochemicals, and oxidative stress 2
-
- Chemotherapy-induced organ toxicity mitigation 4
- Co-authors
- Ahmet Hacımüftüoğlu (7 shared papers)Ufuk Okkay (6 shared papers)Irmak Ferah Okkay (6 shared papers)Cemil Bayram (5 shared papers)Betül Çiçek (4 shared papers)Mustafa Özkaraca (8 shared papers)Halis Süleyman (14 shared papers)Mehtap Kara (3 shared papers)
- Journals
- EXPERIMENTAL ANIMALS (2 papers)Drug and Chemical Toxicology (2 papers)Scientific Reports (1 paper)Gene (1 paper)Life (1 paper)
- Partner nations
- TürkiyeGreeceAzerbaijan
In The Last Decade
Ali Sefa Mendĭl
35 papers receiving 259 citations
Peers
Comparison fields: 5 of 77
- Pharmacology 30
- Hepatology 14
- Complementary and alternative medicine 15
- Pathology and Forensic Medicine 29
- Biochemistry 10
Countries citing papers authored by Ali Sefa Mendĭl
This map shows the geographic impact of Ali Sefa Mendĭl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Sefa Mendĭl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Sefa Mendĭl more than expected).
Fields of papers citing papers by Ali Sefa Mendĭl
This network shows the impact of papers produced by Ali Sefa Mendĭl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Sefa Mendĭl. The network helps show where Ali Sefa Mendĭl may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Sefa Mendĭl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 36 | |
| 2 | 2021 | 26 | |
| 3 | 2021 | 23 | |
| 4 | 2021 | 16 | |
| 5 | 2024 | 15 | |
| 6 | 2021 | 15 | |
| 7 | 2022 | 15 | |
| 8 | 2024 | 11 | |
| 9 | 2022 | 11 | |
| 10 | 2024 | 10 | |
| 11 | 2022 | 9 | |
| 12 | 2022 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2021 | 4 | |
| 19 | 2025 | 3 | |
| 20 | 2025 | 3 |
About Ali Sefa Mendĭl
Ali Sefa Mendĭl is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pharmacology, Cancer Research and Health, Toxicology and Mutagenesis, having authored 41 papers that have together received 263 indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Pineapple and bromelain studies (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Antioxidant Activity and Oxidative Stress (2 papers) and Nigella sativa pharmacological applications (2 papers). The work is most often cited by research in Pharmacology (30 citations), Hepatology (14 citations), Complementary and alternative medicine (15 citations), Pathology and Forensic Medicine (29 citations) and Biochemistry (10 citations). Ali Sefa Mendĭl has collaborated with scholars based in Türkiye, Greece and Azerbaijan. Frequent co-authors include Ahmet Hacımüftüoğlu, Ufuk Okkay, Irmak Ferah Okkay, Cemil Bayram, Betül Çiçek, Mustafa Özkaraca, Halis Süleyman, Mehtap Kara, Çiğdem Sevim and Yeşim Yeni. Their work appears in journals such as EXPERIMENTAL ANIMALS, Drug and Chemical Toxicology, Scientific Reports, Gene and Life.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.